British Media Promotes Woman’s Use Of Turmeric Extract To Recover From Advanced Cancer

In the opening days of 2018, the British media has been promoting the story of a 67-year-old woman, Dieneke Ferguson, who had battled myeloma, a deadly form of blood cancer, for years without success. After enduring three rounds of chemotherapy and four failed attempts at harvesting her stem cells for a transplant, she finally succeeded in halting the disease after ditching conventional approaches and using supplements containing curcumin, a phytobiological extracted from turmeric, instead. Significantly, not only has her story been reported in several British national newspapers, including the country’s two biggest-selling dailies, The Sun and the Daily Mail, it has also featured on primetime television.

For regular visitors to our website, the fact that natural approaches are effective against cancer is of course nothing new. But what is new about Dieneke Ferguson’s story is the fact that the British media is even telling it in the first place. In common with other countries that are major drug markets for the Pharma Cartel, the media in Britain has long been seemingly doing its best to undermine the credibility of natural therapies by publishing regular news reports claiming they are ineffective and dangerous.

While the media’s reporting of Ms. Ferguson’s story was predictably accompanied by warnings that curcumin might not work for everybody and that further research is needed, it is particularly notable that her recovery has also been written up in the British Medical Journal Case Reports. Describing how her cancer had reached an advanced stage and that she was effectively “salvaged” after stopping her conventional treatments and taking curcumin instead, her doctors write that she “remains in a very satisfactory condition with good quality of life”. They conclude that her case provides “further evidence of the potential benefit for curcumin in myeloma”, and recommend “further evaluation of curcumin in myeloma patients in the context of a clinical trial.”

The power of phytobiologicals against cancer

The daily dosage of curcumin used by Dieneke Ferguson, which she continues to take, is 8g a day. By any standards, this certainly constitutes a so-called ‘megadose’. However, as effective as it seems to have been for her, there is more than a grain of truth in the statements made in the British media that taking curcumin alone might not work for all cancer patients. As cancer studies conducted at the Dr. Rath Research Institute under the direction of Dr. Aleksandra Niedzwiecki have clearly shown, for the very best results in the natural control of this disease, carefully chosen balanced combinations of micronutrients are significantly more effective than individual ones used alone.

Known as the micronutrient synergy approach, the results of the studies carried out using this scientific methodology have proven that it can block all key mechanisms that make cancer a deadly disease. These mechanisms include the multiplication of cancer cells and growth of tumors; the formation of new blood vessels to feed tumors (angiogenesis); as well as the invasion and metastasis (spreading) of cancer cells. No less importantly, given that almost all cancer cells are immortal due to their having managed to flip a genetic ‘switch’ in the cell core, the micronutrient synergy approach can also reverse this and induce them to die in a natural process known as apoptosis.

In a study published by the Dr. Rath Research Institute in 2015, a phytobiological synergy combination including curcumin, quercetin, green tea extract, resveratrol, and cruciferous vegetable extracts was shown to significantly inhibit the growth of squamous cell carcinomas of the head and neck. In another paper published the following year, Dr. Rath, Dr. Niedzwiecki and their colleagues summarized the anticancer properties of these phytobiologicals and described how using them in tandem with specific combinations of vitamins, amino acids, and other micronutrients is effective in multiple ways against the development and progression of cancer. They concluded that such therapies should now be considered as safe and effective in the disease’s prevention and treatment. Aided by the British media’s helpful promotion of Dieneke Ferguson’s inspiring story, a chink in the doorway to a new system of healthcare, based on these types of natural cancer approaches, may just have opened a little wider.